21 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
with respect to risk assessment, risk management, loss prevention and regulatory compliance. Oversight by the Audit Committee includes direct … Committee to oversee a periodic assessment by the Board of the Board’s performance. As provided in our Corporate Governance Guidelines, the Nominating
8-K
TYRA
Tyra Biosciences Inc
22 Dec 23
Other Events
9:00am
as an assessment of quality of life and evaluation of biomarkers indicating dose-response relationships to TYRA-300. The Company’s expectation
S-3
EX-1.2
2gxj 5qdtr2wmw60
3 Oct 22
Shelf registration
4:05pm
DEF 14A
lesmx3j5ojkp3z6
28 Apr 22
Definitive proxy
4:07pm
10-K
EX-10.15
4cd1z
3 Mar 22
Annual report
4:31pm
10-K
c1793i8u f86cx3hzh
3 Mar 22
Annual report
4:31pm
10-Q
shq 6d8ca6fa5
3 Nov 21
Quarterly report
4:31pm
424B4
tmaog89
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
EX-1.1
d8wysxyol7u5
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
u52ou r2p1osf6
9 Sep 21
IPO registration (amended)
6:08am
S-1
6osg39z5
20 Aug 21
IPO registration
4:07pm
S-1
EX-10.19
4u4u bwoq
20 Aug 21
IPO registration
4:07pm
DRS/A
3kbc ny8xxem1im
2 Jul 21
Draft registration statement (amended)
12:00am